Home/Pipeline/MDMA-assisted therapy program

MDMA-assisted therapy program

Treatment-resistant mental health conditions

Clinical researchActive

Key Facts

Indication
Treatment-resistant mental health conditions
Phase
Clinical research
Status
Active
Company

About Emyria

Australian biotech developing optimized neurological treatments through advanced drug delivery and clinical data integration.

View full company profile

Therapeutic Areas